Related Tags >> FDA Daniel Vasella GlaxoSmithKline Roche

Novartis News

Most Popular Novartis Story

FDA calls 'all clear' on bone meds

November 13, 2008 — 11:46am ET | By Tracy Staton

Bone drugs Reclast and Fosamax can step out from under a safety cloud, because the FDA came, saw and found nothing. The agency had been reviewing the two meds--sold by Novartis and Merck,... Read more...

Novartis Press Releases

Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
Novartis International ACZ885 Phase III Data Show Rapid, Sustained Clinical Remission In Children And Adults
NexMed Announces $3.5 Million Milestone Payment
Committee For Medicinal Products For Human Use Post-Authorisation Summary Of Positive Opinion For Binocrit
Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale

Latest Headlines

Novartis, Medicis cut generics deals
December 2, 2008
FDA backs pediatric warnings on Zyprexa, Lamisil
November 17, 2008
FDA calls 'all clear' on bone meds
November 13, 2008
FDA approves new labeling for ADHD med
November 12, 2008
Novartis won't sell Biaxin XL copy
October 22, 2008
Novartis to cut reps, reassign execs
October 20, 2008
Novartis - Top 13 Advertising budgets
September 23, 2008
WHO may yank OK for Sandoz meds
September 22, 2008
FDA sends Sandoz warning letter
August 27, 2008
Novartis decision hurts NexMed shares
August 27, 2008
Abbott, Novartis post double-digit profit hikes
July 17, 2008
Psych meds find new market in pets
July 14, 2008
Novartis wraps first phase of Alcon buyout
July 8, 2008
Novartis pares down U.K. distribution
June 12, 2008
Novartis med gets nod for fracture prevention
June 5, 2008
Vasella: 'Teva is better than we are'
June 5, 2008
Novartis buys Protez, invests in vaccines
June 4, 2008
Novartis comes out on top at ASCO
June 3, 2008
Swiss pricing pressure angers Vasella
May 27, 2008
Wyeth pounces on Sandoz's copycat Protonix
May 21, 2008

Paid Research Reports